Literature DB >> 5843084

Glutaminase activity in the kidney in gout.

V E Pollak, H Mattenheimer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5843084

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  13 in total

1.  Anthropometric variables, physical activity and dietary intakes of patients with uric acid nephrolithiasis.

Authors:  Alberto Trinchieri; Emanuele Croppi; Giovanni Simonelli; Carmine Sciorio; Emanuele Montanari
Journal:  Urolithiasis       Date:  2019-04-29       Impact factor: 3.436

Review 2.  Pathophysiology of hyperuricemia in primary gout.

Authors:  J B Wyngaarden
Journal:  Trans Am Clin Climatol Assoc       Date:  1970

3.  A reappraisal of the concept of an abnormality of glutamine metabolism in primary gout.

Authors:  J B Wyngaarden; O Sperling; F Starmer
Journal:  Trans Am Clin Climatol Assoc       Date:  1973

4.  [On the urine acidity in patients with uric acid stones].

Authors:  E Matouschek; R Böwering
Journal:  Klin Wochenschr       Date:  1968-09-15

5.  Plasma and urinary amino acids in primary gout, with special reference to glutamine.

Authors:  T F Yü; M Adler; E Bobrow; A B Gutman
Journal:  J Clin Invest       Date:  1969-05       Impact factor: 14.808

6.  Progress in screening for inborn errors of metabolism.

Authors:  R W Watts
Journal:  Experientia       Date:  1978-02-15

7.  [Glutamine synthetase activity in the liver in primary gout (author's transl)].

Authors:  H Becher; D Mecke; R Kleinen; D P Mertz
Journal:  Klin Wochenschr       Date:  1974-04-15

8.  Biochemical and dietary factors of uric acid stone formation.

Authors:  Alberto Trinchieri; Emanuele Montanari
Journal:  Urolithiasis       Date:  2017-02-28       Impact factor: 3.436

Review 9.  Recent advances in the pathophysiology of nephrolithiasis.

Authors:  Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-12-10       Impact factor: 10.612

10.  The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout.

Authors:  O Sperling; J B Wyngaarden; C F Starmer
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.